该研究小组的重点是以人为本，安全有效地使用药物和改善公共卫生。我们的目标是最大限度地利用苏格兰丰富的健康信息学数据集，包括新的个人水平处方数据集，以支持分层医学方法并研究干预措施对公共卫生的影响。该计划侧重于：药物依从性，临床结果，现实世界临床实践中的毒性。我们负责Farr Institute的药物流行病学计划。它着重于心血管和免疫疗法，并在呼吸系统疾病，癌症和感染方面有补充计划。我们还领导了新的苏格兰医疗保健相关感染预防研究所内的临床感染信息学工作流程。我们的临床“学术药物流行病学”网络已嵌入本地NHS
Our aim is to maximise the use of Scotland's rich health informatics datasets, including the new individual level prescribing dataset, to support stratified medicine approaches and investigate the impact of interventions on public health.<br><br>The programme focuses on:<br><br>medicine adherence<br>clinical outcomes<br>toxicities in real world clinical practice<br>We lead the Farr Institute pharmacoepidemiology programme. This focuses on cardiovascular and immunological therapies and have complementary programmes in respiratory disease, cancer and infection.<br><br>We also lead the clinical infection informatics work stream within the new Scottish Healthcare Associated Infection Prevention Institute. Our clinical–academic pharmacoepidemiology network is embedded in local NHS systems and links with other international research networks.